Negocie Bayer BAYGn

Venda
 Comprar

Gráfico Bayer ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Últimas notícias

Tommy Yap 2025 Mar 26, 16:00

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Morning Note USD CAD Cryptocurrencies
Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed
Tommy Yap 2025 Mar 25, 16:00

Morning Note: S&P 500 Surges on Tariff Optimism as Tesla Jumps 10%

Morning Note S&P 500 TSLA Oil
Tommy Yap 2025 Mar 25, 16:00

Morning Note: Australia’s Inflation Cools, Japan’s Stays High, UK Awaits Data

Morning Note AUD USD JPY GBP
Frances Wang 2025 Mar 24, 16:00

Pepe coin news today: where will Pepe coin price go in 2025?

Cryptocurrencies
Frances Wang 2025 Mar 24, 16:00

USD/JPY news today: Will USD/JPY Break 150?

Forex
Tommy Yap 2025 Mar 23, 16:00

Morning Note: Nvidia’s $1 Trillion Data Centre Bet, SEC Crypto Rules, US PMI Data

Morning Note NVDA Cryptocurrencies CPI
Tommy Yap 2025 Mar 22, 16:00

Week Ahead: Investor Eyes on U.S. Inflation & Core PCE for Fed’s Next Move

Forex Indices

Info

Spread

0.15

Spread (%)

0.6699 %

Alavancagem

1:10

Juro overnight, Compra

-0.0556 %

Juro overnight, Venda

-0.0333 %

Moeda

EUR

Horários de Negociação

Mercado aberto

Quinta-feira

08:02 - 11:59

Segunda-feira

07:02-10:59

Segunda-feira

11:04-15:29

Terça-feira

07:02-10:59

Terça-feira

11:04-15:29

Quarta-feira

07:02-10:59

Quarta-feira

11:04-15:29

Sexta-feira

08:02-11:59

Sexta-feira

12:04-16:29

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

23155732480

Ações em circulação

982424000

Data dos rendimentos (Próxima)

2018-06-06

Rendim Divid

Data Ex-Dividendos

2025-04-28

Taxa anual futura de dividendos

0.11

Rendimento anual futuro de dividendos

0.0046

EPS

-2.6

Saiba mais sobre este instrumento

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed management as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular, renal, and gynecological diseases; collaboration agreement with Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados
Trustpilot